Alzheimer's disease

Citations 511-520 of 578 total displayed.

Past content (since Jan 2001):

ARTICLES
The prevalence of frontotemporal dementia

E. Ratnavalli, C. Brayne, K. Dawson, and J. R. Hodges
Neurology 2002; 58: 1615-1621. [Abstract] [Full text] [PDF]  

ARTICLES
Effects of subcortical ischemic vascular dementia and AD on entorhinal cortex and hippocampus

A. T. Du, N. Schuff, M. P. Laakso, X. P. Zhu, W. J. Jagust, K. Yaffe, J. H. Kramer, B. L. Miller, B. R. Reed, D. Norman, H. C. Chui, and M. W. Weiner
Neurology 2002; 58: 1635-1641. [Abstract] [Full text] [PDF]  

EDITORIALS
Food (and vitamins) for thought

James F. Toole and Clifford R. Jack
Neurology 2002; 58: 1449-1450. [Full text] [PDF]  

ARTICLES
Homocysteine, vitamin B₆, and vascular disease in AD patients

J. W. Miller, R. Green, D. M. Mungas, B. R. Reed, and W. J. Jagust
Neurology 2002; 58: 1471-1475. [Abstract] [Full text] [PDF]  

ARTICLES
Hippocampal volume as an index of Alzheimer neuropathology: Findings from the Nun Study

K. M. Gosche, J. A. Mortimer, C. D. Smith, W. R. Markesbery, and D. A. Snowdon
Neurology 2002; 58: 1476-1482. [Abstract] [Full text] [PDF]  

BRIEF COMMUNICATIONS
Are interleukin-1 gene polymorphisms risk factors or disease modifiers in AD?

E. K. Green, J. M. Harris, H. Lemmon, J. C. Lambert, M. C. Chartier–Harlin, D. St. Clair, D. M.A. Mann, T. Iwatsubo, and C. L. Lendon
Neurology 2002; 58: 1566-1568. [Abstract] [Full text] [PDF]  

CLINICAL/SCIENTIFIC NOTES
Symptoms of B₁₂ deficiency can occur in women of child bearing age supplemented with folate

Joseph Drazkowski, Joseph Sirven, and David Blum
Neurology 2002; 58: 1572-1573. [Full text] [PDF]  

CLINICAL/SCIENTIFIC NOTES
An Iranian family with Alzheimer’s disease caused by a novel APP mutation (Thr714Ala)

P. Pasalar, H. Najmabadi, A. R. Noorian, B. Moghimi, A. Jannati, A. Soltanzadeh, T. Krefft, R. Crook, and J. Hardy
Neurology 2002; 58: 1574-1575. [Full text] [PDF]  

MEDICAL HYPOTHESIS
Functional vitamin B₁₂ deficiency and Alzheimer disease

A. McCaddon, B. Regland, P. Hudson, and G. Davies
Neurology 2002; 58: 1395-1399. [Abstract] [Full text] [PDF]  

BRIEF COMMUNICATIONS
Prednisolone (30–60 mg/day) for diseases other than AD decreases amyloid ß-peptides in CSF

T. Tokuda, T. Oide, A. Tamaoka, K. Ishii, S. Matsuno, and S. Ikeda
Neurology 2002; 58: 1415-1418. [Abstract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58